Gerne geben wir Ihnen hier einen Überblick über die letzten Publikationen aus der von unterstützten Lungenkrebs-Forschung:
Jahr 2024
- Forschungsprojekt: Immune cell profiling of oligo-metastatic non-small cell lung cancer patients
- European Journal of Cardio-Thoracic Surgery, 2024, Dr. Raphael S. Werner 2024_Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases
Jahr 2023
- Forschungsprojekt: Overcoming Resistance to immunotherapy for thoracic malignancies
- Nature communications, 2023, Prof. A. Curioni: Curioni_Nature Communications_2023[4]
- Forschungsprojekt: Lung Cancer Screening
-
-
- MDPI, 2023, Dr. med. Lisa Jungblut:jcm-12-05771-v2
-
-
Jahr 2022
- Forschungsprojekt: RNA editing in mesothelioma
- MDPI, 2022, Dr. Felley-Bosco: Felley_Bosco_Sun et al Cancer Letters2021
- IASLC, JTO Clinical and Research Report, 2022, Dr. Felley-Bosco: IASLC_JTO_Clinicalandresearch_Reports
- Molecular Oncology, 2022, Dr. Felley-Bosco: Molecular Oncology – 2022 – Landscape of RNA editing in human mesothelioma
- British Journal of Cancer, 2022, Dr. Felley-Bosco: British Journal of Cancer 2022
- IASLC, Journal of Thoracic Oncology, 2022, Dr. Felley-Bosco IASLC_Journal_of_Thoracic_Oncology
- Frontiers in Oncology, 2022, Dr. Felley-Bosco: Frontiers in Oncology-871544
- Nature Communications, 2022, Dr. Felley-Bosco: Nature_Communication_s41467-022-29311-7
- Forschungsprojekt: Overcoming resistance to immunotherapy for thoracic malignancies
- Cancers,2022, Dr. Curioni: Curioni_Manuscript Statistics NSCLC Immunotherpy
- Targeted Oncology (2022) 17:683–694, Prof. Curioni: Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations
- Forschungsprojekt: A novel integrative approach to characterize and exploit the proteomic landscape in metastatic lung cancer
- EMBO Molecular Medicine, 2022, Prof. Weller: Weller_Zhu et al EMBO Mol Med – 2022
- Forschungsprojekt: Liquid biopsy and ex vivo drug sensitivity profiling in patients with brain metastases from lung cancer
- Nature Medicine, 2022, Dr. med. Emilie Le Run: Weller_Nature Medicine
- Forschungsprojekt: Lung Cancer Screening
-
- Swiss Medical Weekly, 2022, Dr. med. Lisa Jungblut: Jungblut 2022 – SMW – screening[2]
-
2021
- Forschungsprojekt : RNA editing in mesothelioma
- Elsevier, Cancer Letters, 2021, Dr. Felley-Bosco: Felley_Bosco_Sun et al Cancer Letters2021
- Precicion Cancer Medicine, 2021, Dr. Felley-Bosco: Felley-Bosco2021 6382-PB8-3944-R3
- Forschungsprojekt: Exploring the interactome of ADAM17 in the tumor microenvironment and its role for radiation resistance
- AACR Journals, 2021, Dr. Knobel : Knobel_Tschanz et al., 2021
Jahr 2020
- Forschungsprojekt : Competition of glucose uptake between cancer cells and immune system: understanding the role of FDG-PET in non-small cell lung cancer patients undergoing immunotherapy.
- Clinical Nuclear Medicine, 2020, Dr. Curioni: Curioni_18F_FET_PET_for_Diagnosis_of_Pseudoprogression_of.4